Menu

Home / For Visitors / 2022 Exhibitor List / ALAR PHARMACEUTICALS INC.

ALAR PHARMACEUTICALS INC.

Area: Government, Academia and Research Institutes

Booth No: S610

Website: https://alarpharm.com/

Exhibitor Profile

Alar Pharm, a new drug development company, focuses on developing long-acting release injectables (LAIs) for treating central nervous system disorders & chronic diseases, including opioid use disorder, alcohol use disorder, chronic pain, treatment-resistant depression, and Parkinson's disease mainly. Our LAIs have distinctive characteristics such as low viscosity, small injection volume, and smooth drug release profile with fewer side effects, which provide better medication choices to patients.

Brands

ALA-1000, ALA-3000, ALA-4000

Exhibit Products

Exhibitor Press Release

Alar Announces Significant Progress on Developing Long-acting Buprenorphine Injectable ALA-1000 2022-05-13

Exhibitors you may be interested in

Highest Rated

TOP